Elizabeth T. O'Neill - Mar 25, 2019 Form 4/A - Amendment Insider Report for LEVI STRAUSS & CO (LEVI)

Signature
/s/ Priscilla Duncan-Tannous, Attorney-in-Fact
Stock symbol
LEVI
Transactions as of
Mar 25, 2019
Transactions value $
$0
Form type
4/A - Amendment
Date filed
4/21/2023, 06:29 PM
Date Of Original Report
Mar 27, 2019
Next filing
Jan 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LEVI Common Stock Other $0 -2.76K -5.02% $0.00 52.2K Mar 25, 2019 Direct F1
transaction LEVI Common Stock Other $0 -52.2K -100% $0.00* 0 Mar 25, 2019 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEVI Class B Common Stock Other $0 +2.76K $0.00 2.76K Mar 25, 2019 Class A Common Stock 2.76K Direct F1
transaction LEVI Class B Common Stock Other $0 +52.2K +1890.94% $0.00 55K Mar 25, 2019 Class A Common Stock 52.2K Direct F1, F2, F3
transaction LEVI Stock Appreciation Rights Other $0 -55.9K -100% $0.00* 0 Mar 25, 2019 Common Stock 55.9K $14.88 Direct F1, F4, F5
transaction LEVI Stock Appreciation Rights Other $0 +55.9K $0.00 55.9K Mar 25, 2019 Class B Common Stock 55.9K $14.88 Direct F1, F4, F5
transaction LEVI Stock Appreciation Rights Other $0 -66.9K -100% $0.00* 0 Mar 25, 2019 Common Stock 66.9K $9.60 Direct F1, F4, F6
transaction LEVI Stock Appreciation Rights Other $0 +66.9K $0.00 66.9K Mar 25, 2019 Class B Common Stock 66.9K $9.60 Direct F1, F4, F6
transaction LEVI Stock Appreciation Rights Other $0 -93K -100% $0.00* 0 Mar 25, 2019 Common Stock 93K $6.90 Direct F1, F4, F7
transaction LEVI Stock Appreciation Rights Other $0 +93K $0.00 93K Mar 25, 2019 Class B Common Stock 93K $6.90 Direct F1, F4, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately prior to the closing of the Issuer's initial public offering, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F2 This Form 4/A is being filed to correct the disclosure relating to RSUs set forth in the Form 4 filed on March 27, 2019 (the "Original Form 4"), which were inadvertently disclosed in Table I instead of Table II in the Original Form 4.
F3 Each share is represented by a restricted stock unit (RSU) that may be settled in shares of Class B Common Stock. Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Of these RSUs, (i) 21,730 RSUs vest on February 1, 2020, (ii) 13,660 RSUs vest in four equal annual installments beginning on January 30, 2019, and (iii) 16,800 RSUs vest in four equal annual installments beginning on January 30, 2020.
F4 Each stock appreciation right (SAR) represents the right to receive, upon exercise, shares of the Issuer's Common Stock (and, after the conversion noted in footnote (1), Class B Common Stock) with a value equal to the increase in the fair market value of one share of such stock from the date of grant of the SAR.
F5 25% of the SARs vest on January 30, 2020, and 1/3 of the remaining SARs vest annually beginning on January 30, 2021.
F6 25% of the SARs vested on January 30, 2019, and 1/3 of the remaining SARs vest annually beginning on January 30, 2020.
F7 25% of the SARs vested on February 1, 2018, and 1/3 of the remaining SARs vest annually beginning on February 1, 2019.